| 1 |
Zhang H, Tang X, Feng C, Gao Y, Hong Q, Zhang J, Zhang X, Zheng Q, Lin J, Liu X, Shen L. The use of data independent acquisition based proteomic analysis and machine learning to reveal potential biomarkers for autism spectrum disorder. J Proteomics 2023;278:104872. [PMID: 36898611 DOI: 10.1016/j.jprot.2023.104872] [Reference Citation Analysis]
|
| 2 |
Swaroop S, Adlakha YK. Crosstalk between microRNAs and epigenetics during brain development and neurological diseases. Transcription and Translation in Health and Disease 2023. [DOI: 10.1016/b978-0-323-99521-4.00009-x] [Reference Citation Analysis]
|
| 3 |
Anderson G. Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub. Int J Mol Sci 2022;24. [PMID: 36613794 DOI: 10.3390/ijms24010350] [Reference Citation Analysis]
|
| 4 |
Yan X, Yao J, Li Y, Zhang W, Xi M, Chen M, Li Y. Global trends in research on miRNA–microbiome interaction from 2011 to 2021: A bibliometric analysis. Front Pharmacol 2022;13:974741. [DOI: 10.3389/fphar.2022.974741] [Reference Citation Analysis]
|
| 5 |
Bogdanova OV, Bogdanov VB, Pizano A, Bouvard M, Cazalets JR, Mellen N, Amestoy A. The Current View on the Paradox of Pain in Autism Spectrum Disorders. Front Psychiatry 2022;13:910824. [PMID: 35935443 DOI: 10.3389/fpsyt.2022.910824] [Reference Citation Analysis]
|
| 6 |
Chernikova MA, Flores GD, Kilroy E, Labus JS, Mayer EA, Aziz-Zadeh L. The Brain-Gut-Microbiome System: Pathways and Implications for Autism Spectrum Disorder. Nutrients 2021;13:4497. [PMID: 34960049 DOI: 10.3390/nu13124497] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 7 |
Gevezova M, Sarafian V, Anderson G, Maes M. Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder. CNS Neurol Disord Drug Targets 2020;19:320-33. [PMID: 32600237 DOI: 10.2174/1871527319666200628015039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 8 |
Abdul F, Sreenivas N, Kommu JVS, Banerjee M, Berk M, Maes M, Leboyer M, Debnath M. Disruption of circadian rhythm and risk of autism spectrum disorder: role of immune-inflammatory, oxidative stress, metabolic and neurotransmitter pathways. Rev Neurosci 2021. [PMID: 34047147 DOI: 10.1515/revneuro-2021-0022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin in autism: Association with tumor necrosis factor and sleep disturbances. J Pineal Res 2021;70:e12715. [PMID: 33421193 DOI: 10.1111/jpi.12715] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Moradi K, Ashraf-Ganjouei A, Tavolinejad H, Bagheri S, Akhondzadeh S. The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways. Prog Neuropsychopharmacol Biol Psychiatry 2021;106:110091. [PMID: 32891667 DOI: 10.1016/j.pnpbp.2020.110091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 11 |
Coppola S, Avagliano C, Calignano A, Berni Canani R. The Protective Role of Butyrate against Obesity and Obesity-Related Diseases. Molecules 2021;26:682. [PMID: 33525625 DOI: 10.3390/molecules26030682] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 12 |
Anderson G, Maes M. Sirtuins, mitochondria, and the melatonergic pathway in Alzheimer’s disease. Sirtuin Biology in Medicine 2021. [DOI: 10.1016/b978-0-12-814118-2.00015-x] [Reference Citation Analysis]
|
| 13 |
Banks WA. A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases. Curr Pharm Des 2020;26:1-5. [PMID: 32122292 DOI: 10.2174/138161282601200225102049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 14 |
Anderson G. Autism Spectrum Disorder: Pathophysiology and Treatment Implications. Curr Pharm Des 2019;25:4319-20. [PMID: 31942847 DOI: 10.2174/138161282541191230102715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 15 |
Maes M, Anderson G, Betancort Medina SR, Seo M, Ojala JO. Integrating Autism Spectrum Disorder Pathophysiology: Mitochondria, Vitamin A, CD38, Oxytocin, Serotonin and Melatonergic Alterations in the Placenta and Gut. Curr Pharm Des 2019;25:4405-20. [PMID: 31682209 DOI: 10.2174/1381612825666191102165459] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 16 |
Anderson G, Maes M. Gut Dysbiosis Dysregulates Central and Systemic Homeostasis via Suboptimal Mitochondrial Function: Assessment, Treatment and Classification Implications. CTMC 2020;20:524-39. [DOI: 10.2174/1568026620666200131094445] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 17 |
Ivanov DO, Evsyukova II, Mazzoccoli G, Anderson G, Polyakova VO, Kvetnoy IM, Carbone A, Nasyrov RA. The Role of Prenatal Melatonin in the Regulation of Childhood Obesity. Biology (Basel) 2020;9:E72. [PMID: 32260529 DOI: 10.3390/biology9040072] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
